ABERA BIOSCIENCE AB (8WK) — Cash Flow Quality Index
Latest as of March 2025:
-49.17x
ABERA BIOSCIENCE AB (8WK) has a Cash Flow Quality Index of -49.17x as of March 2025. Operating cash flow of €-590.00K is below net income of €12.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore ABERA BIOSCIENCE AB assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
-49.17x
Operating CF / Net Income
Operating Cash Flow
€-590.00K
EUR
Net Income
€12.00K
EUR
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for ABERA BIOSCIENCE AB (None–None)
Year-by-year earnings quality comparison for ABERA BIOSCIENCE AB. For live market cap and the full company financial profile, see ABERA BIOSCIENCE AB market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.